Search clinical trials for: Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease

Total 2 results

Assistance Publique - Hôpitaux de Paris
Pfizer

Recruiting

Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor (HEMOPROVE)

Sickle Cell Disease

France
Memorial Sloan Kettering Cancer Center
Tufts Medical Center; Lahey Clinic

Completed

Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L

Multiple Myeloma

United States

3

Subscribe